Blue Cross and Blue Shield of South Carolina
Insurance provider
Based in SC
🤖
AI Overview
With $525K in lobbying spend across 27 quarterly filings, Blue Cross and Blue Shield of South Carolina is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2024.
$525K
Total Spend
7
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $80K |
| 2020 | $80K |
| 2021 | $80K |
| 2022 | $80K |
| 2023 | $80K |
| 2024 | $45K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Defense, Health Issues
- •Processing of Durable Medical Equipment (DME) claims and the Centers for Medicare and Medicaid Services (CMS) Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Program
- •Proposals of the Military Compensation and Retirement Modernization Commission relating to health care delivery and legislative activity concerning military health care reform and the TRICARE Program
- •General health care issues, including, legislative initiatives relating to the "Affordable Care Act" and payment policies
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.